Company Filing History:
Years Active: 2018-2021
Title: Innovations by Luis Pascual Jodar Martin-Montalvo
Introduction
Luis Pascual Jodar Martin-Montalvo is a notable inventor based in Villanova, PA (US). He has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions. With a total of 2 patents, his work focuses on enhancing vaccination strategies against pneumococcal infections.
Latest Patents
One of his latest patents is titled "Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof." This invention relates to new immunogenic compositions that include conjugated capsular saccharide antigens, also known as glycoconjugates. The compositions are designed to include at least one glycoconjugate from a serotype not found in existing vaccines such as PREVNAR®, SYNFLORIX®, and PREVNAR 13®. The invention aims to improve vaccination for human subjects, particularly infants and the elderly, against pneumococcal infections.
Career Highlights
Luis Pascual Jodar Martin-Montalvo is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to contribute to groundbreaking research and development in immunology.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues, including Wendy Jo Watson and Raul Enrique Isturiz. These collaborations have further enriched his research and innovation efforts.
Conclusion
Luis Pascual Jodar Martin-Montalvo's contributions to immunology through his patents and work at Pfizer highlight his commitment to advancing healthcare solutions. His innovative approaches to vaccination are paving the way for improved public health outcomes.